Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Cincinnati Veterans Affairs Medical Center, Cincinnati, Ohio, USA.
FASEB J. 2019 Mar;33(3):3825-3840. doi: 10.1096/fj.201802015R. Epub 2018 Dec 12.
Levels of augmenter of liver regeneration (ALR), a multifunctional protein, are reduced in steatohepatitis. ALR depletion from ALR /Alb-Cre [ALR-L-knockout (KO)] mouse causes robust steatosis and apoptosis of hepatocytes, and pericellular fibrosis between 1 and 2 wk postbirth. Steatosis regresses by 4 wk upon reappearance of ALR-expressing hepatocytes. We investigated mechanisms of ALR depletion-induced steatosis. ALR-L-KO mice (1-, 2-, and 4 wk old) and Adeno-Cre-transfected ALR hepatocytes were used for in vivo and in vitro studies. ALR depletion from hepatocytes in vivo downregulated peroxisome proliferator-activated receptor (PPAR)-α, carnitine palmitoyl transferase I (CPT1)a, peroxisomal membrane protein 70 (PMP70) (modest down-regulation), and acyl-CoA oxidase 1 (ACOX1). The markedly up-regulated (20X) novel microRNA-540 (miR-540) was identified to target PPARα, PMP70, ACOX1, and CPT1a. ALR depletion from primary hepatocytes increased oxidative stress, miR-540 expression, and steatosis and down-regulated PPARα, ACOX1, PMP70, and CPT1a expression. Anti-miR-540 mitigated ALR depletion-induced steatosis and prevented loss of PPARα, ACOX1, PMP70, and CPT1a expression. Antioxidant N-acetylcysteine and recombinant ALR (rALR) both inhibited ALR depletion-induced miR-540 expression and lipid accumulation in hepatocytes. Finally, treatment of ALR-L-KO mice with rALR between 1 and 2 wk prevented miR-540 expression, and arrested steatosis and fibrosis. We conclude that ALR deficiency-mediated oxidative stress induces generation of miR-540, which promotes steatosis by dysregulating peroxisomal and mitochondrial lipid homeostasis.-Kumar, S., Rani, R., Karns, R., Gandhi, C. R. Augmenter of liver regeneration protein deficiency promotes hepatic steatosis by inducing oxidative stress and microRNA-540 expression.
肝再生增强因子(ALR)是一种多功能蛋白,其水平在脂肪性肝炎中降低。从 ALR/ Alb-Cre [ALR-L-敲除(KO)] 小鼠中耗尽 ALR 会导致出生后 1 至 2 周内肝实质细胞发生明显的脂肪变性和凋亡,并伴有细胞周纤维化。4 周时,随着表达 ALR 的肝细胞的重新出现,脂肪变性会消退。我们研究了 ALR 耗竭诱导脂肪变性的机制。体内和体外研究使用了 ALR-L-KO 小鼠(1、2 和 4 周龄)和腺病毒-Cre 转染的 ALR 肝细胞。体内从肝细胞中耗尽 ALR 会下调过氧化物酶体增殖物激活受体(PPAR)-α、肉碱棕榈酰转移酶 I(CPT1)a、过氧化物酶体膜蛋白 70(PMP70)(适度下调)和酰基辅酶 A 氧化酶 1(ACOX1)。鉴定出显著上调(20 倍)的新型 microRNA-540(miR-540)作为 PPARα、PMP70、ACOX1 和 CPT1a 的靶标。从原代肝细胞中耗尽 ALR 会增加氧化应激、miR-540 的表达和脂肪变性,并下调 PPARα、ACOX1、PMP70 和 CPT1a 的表达。抗-miR-540 减轻了 ALR 耗竭诱导的脂肪变性,并防止了 PPARα、ACOX1、PMP70 和 CPT1a 的表达丧失。抗氧化剂 N-乙酰半胱氨酸和重组 ALR(rALR)均抑制了肝细胞中 ALR 耗竭诱导的 miR-540 表达和脂质积累。最后,在 1 至 2 周期间用 rALR 治疗 ALR-L-KO 小鼠可防止 miR-540 的表达,并阻止脂肪变性和纤维化的发生。我们的结论是,ALR 缺失介导的氧化应激诱导了 miR-540 的产生,通过扰乱过氧化物酶体和线粒体脂质稳态,促进了脂肪变性。